Transplant-Eligible Colorectal Liver Metastasis Patients Treated with Hepatic Artery Infusion Pump – A Retrospective Cohort Study
In this cohort, less than 5% of unresectable CRLM patients were LT-eligible. After treatment with HAIP chemotherapy, overall 5-year survival was 53%, similar to a recent LT randomized trial (5-year OS 57%).
Authors
- A. Cercek
- Louise C. Connell (ORCID: https://orcid.org/0000-0002-3193-4629)
- Nancy Kemeny
- Pratik Chandra (ORCID: https://orcid.org/0009-0008-1243-4865)
- J. Chou
- Jeffrey A. Drebin (ORCID: https://orcid.org/0000-0003-2312-2062)
- A. Wei
- Michael D’Angelica
- William R. Jarnagin
- Kevin Soares
- Vinod Balachandran
- Rebecca Herbert
- Mithat Gonen
- William Preston
- T. Peter Kingham
Institutions
- Memorial Sloan Kettering Cancer Center (US)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1097/sla.0000000000007021
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00